Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Milaberon in Combination With Standard Therapy in Advanced Solid Tumors: an Open, Multicenter, Clinical Study

NCT06534762 is registered in ClinicalTrials.gov with Zhejiang Provincial People's Hospital as lead sponsor.

NCT NCT06534762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06534762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Milaberon in Combination With Standard Therapy in Advanced Solid Tumors: an Open, Multicenter, Clinical Study
Lead sponsor
Zhejiang Provincial People's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
July 15, 2024
Completion date
July 1, 2028
Enrollment
260 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, dlbcl - diffuse large b cell lymphoma, nsclc, pancreas cancer, sclc, squamous cell carcinoma of head and neck, tnbc - triple-negative breast cancer